Ammonia hydroxide → 4-(4-morpholino-6-((4-N-methylsulfonylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)pyridin-2-amine

HRID 391141

反応式

HRID 391141 の反応式
F[C:2]1[CH:7]=[C:6]([C:8]2[N:9]=[C:10]([N:28]3[CH2:33][CH2:32][O:31][CH2:30][CH2:29]3)[C:11]3[S:16][C:15]([CH2:17][N:18]4[CH2:23][CH2:22][N:21]([S:24]([CH3:27])(=[O:26])=[O:25])[CH2:20][CH2:19]4)=[CH:14][C:12]=3[N:13]=2)[CH:5]=[CH:4][N:3]=1.[OH-].[NH3:35]>>[CH3:27][S:24]([N:21]1[CH2:22][CH2:23][N:18]([CH2:17][C:15]2[S:16][C:11]3[C:10]([N:28]4[CH2:33][CH2:32][O:31][CH2:30][CH2:29]4)=[N:9][C:8]([C:6]4[CH:5]=[CH:4][N:3]=[C:2]([NH2:35])[CH:7]=4)=[N:13][C:12]=3[CH:14]=2)[CH2:19][CH2:20]1)(=[O:26])=[O:25]

参加物

3

実験手順

2-(2-Fluoro-pyridin-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (107 mg) was heated in ammonia hydroxide (90 ml) in a sealed stainless steel pressurized vessel at 150° C. for 5 days. Extraction into chloroform and purification on silica afforded 418 (57 mg). NMR (CDCl3): 2.67-2.71 (4H, m), 2.81 (3H, s), 3.29-3.33 (4H, m), 3.89 (2H, s), 3.89-3.93 (4H, m), 4.08-4.12 (4H, m), 4.55 (2H, br s), 7.36 (1H, s), 7.54 (1H, s), 7.65 (1H, d, J=5.3), 8.21 (1H, d, J=5.3) MS (ESI+): MH+ 490.16 (74%)

後処理

  1. extractionExtraction
  2. custominto chloroform and purification on silica

出典と根拠

ORDレコード
ord-1150a56a28d54bdfa2e3f1e8461e5529
出典データセット
uspto-grants-2013_02
特許番号
US08383620B2

関連ノート

読み込み中…